|
OMIM |
Link |
Information gain |
01 |
|
hemophilia a
|
[NCBI]
|
0.00960393
|
|
|
HEMB
|
[NCBI]
|
0.0014375
|
|
|
F5F8D
|
[NCBI]
|
0.00133431
|
|
|
GPS
|
[NCBI]
|
0.0012827
|
|
|
lipoprotein types--ld system
|
[NCBI]
|
0.00119841
|
|
|
xm system
|
[NCBI]
|
0.00098052
|
|
|
CVD1
|
[NCBI]
|
0.000844965
|
|
|
von willebrand disease
|
[NCBI]
|
0.000576453
|
|
|
F3
|
[NCBI]
|
0.000423725
|
|
|
LMAN1
|
[NCBI]
|
0.000375425
|
|
|
factor viii deficiency
|
[NCBI]
|
0.000353129
|
|
|
von willebrand disease, x-linked form
|
[NCBI]
|
0.000235159
|
|
|
F8FD9
|
[NCBI]
|
0.000235159
|
|
|
factors viii, ix and xi, combined deficiency of
|
[NCBI]
|
0.000235159
|
|
|
factor vii and factor viii, combined deficiency of
|
[NCBI]
|
0.000204216
|
|
|
TFPI
|
[NCBI]
|
0.000195213
|
|
|
multiple coagulation factor deficiency protein 2
|
[NCBI]
|
0.000187546
|
|
|
factor xii deficiency
|
[NCBI]
|
0.000133554
|
|
|
factor ix and factor xi, combined deficiency of
|
[NCBI]
|
0.000117451
|
|
|
hemophilia a with vascular abnormality
|
[NCBI]
|
0.000117451
|
|
|
factor v and factor viii, combined deficiency of, with normal protein c and protein c inhibitor
|
[NCBI]
|
0.000117451
|
|
|
glanzmann thrombasthenia, autosomal dominant
|
[NCBI]
|
9.49899e-05
|
|
|
TNF
|
[NCBI]
|
9.44007e-05
|
|
|
LRE1
|
[NCBI]
|
9.15979e-05
|
|
|
geographic tongue and fissured tongue
|
[NCBI]
|
8.65192e-05
|
|
|
corticosteroid-binding globulin deficiency
|
[NCBI]
|
8.10223e-05
|
|
|
PCI
|
[NCBI]
|
7.68181e-05
|
|
|
factor vii deficiency
|
[NCBI]
|
7.55986e-05
|
|
|
australia antigen
|
[NCBI]
|
7.36852e-05
|
|
|
hydroxyacyl-coa dehydrogenase ii deficiency
|
[NCBI]
|
7.09823e-05
|
|
|
BDE
|
[NCBI]
|
6.867e-05
|
|
|
pseudo-von willebrand disease
|
[NCBI]
|
6.867e-05
|
|
|
CPB2
|
[NCBI]
|
6.69477e-05
|
|
|
von willebrand disease, recessive form
|
[NCBI]
|
6.17799e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
6.17102e-05
|
|
|
vitamin k-dependent clotting factors, combined deficiency of, 1
|
[NCBI]
|
5.92022e-05
|
|
|
anemia, dyserythropoietic congenital, type i
|
[NCBI]
|
5.50398e-05
|
|
|
BRCC3
|
[NCBI]
|
4.87162e-05
|
|
|
F8A
|
[NCBI]
|
4.87162e-05
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
4.72588e-05
|
|
|
CCR5
|
[NCBI]
|
4.12786e-05
|
|
|
HAE
|
[NCBI]
|
3.5682e-05
|
|
|
LNS
|
[NCBI]
|
3.39594e-05
|
|
|
EGF
|
[NCBI]
|
3.26248e-05
|
|
|
ALS1
|
[NCBI]
|
3.08344e-05
|
|
|
CJD
|
[NCBI]
|
2.95236e-05
|
|
|
NS1
|
[NCBI]
|
2.81125e-05
|
|
|
AHO
|
[NCBI]
|
2.78063e-05
|
|
|
giant platelet syndrome
|
[NCBI]
|
2.69261e-05
|
|
|
F12
|
[NCBI]
|
2.62159e-05
|
|
|
SELP
|
[NCBI]
|
2.62159e-05
|
|
|
LRP1
|
[NCBI]
|
2.57601e-05
|
|
|
IP
|
[NCBI]
|
2.31063e-05
|
|
|
HLA-B
|
[NCBI]
|
2.28838e-05
|
|
|
COL4A5
|
[NCBI]
|
1.88167e-05
|
|
|
DMD
|
[NCBI]
|
1.86975e-05
|
|
|
pta deficiency
|
[NCBI]
|
1.85246e-05
|
|
|
TSD
|
[NCBI]
|
1.81776e-05
|
|
|
RA
|
[NCBI]
|
1.81603e-05
|
|
|
EPO
|
[NCBI]
|
1.79123e-05
|
|
|
RS1
|
[NCBI]
|
1.69514e-05
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
1.62907e-05
|
|
|
factor x deficiency
|
[NCBI]
|
1.58301e-05
|
|
|
KAL1
|
[NCBI]
|
1.44764e-05
|
|
|
mucopolysaccharidosis type iva
|
[NCBI]
|
1.41273e-05
|
|
|
FGA
|
[NCBI]
|
1.19068e-05
|
|
|
factor v deficiency
|
[NCBI]
|
1.08293e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.00885e-05
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
8.76377e-06
|
|
|
HPRT1
|
[NCBI]
|
8.32447e-06
|
|
|
IFNA1
|
[NCBI]
|
6.63685e-06
|
|
|
PWS
|
[NCBI]
|
3.32529e-06
|
|
|
AFP
|
[NCBI]
|
2.39712e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.19076e-06
|
|
|
IL2
|
[NCBI]
|
1.50046e-06
|
|
|
ADA
|
[NCBI]
|
1.00069e-06
|
|
|
PF4
|
[NCBI]
|
7.68483e-07
|
|
|
ALB
|
[NCBI]
|
5.73262e-07
|
|
|
SLE
|
[NCBI]
|
1.09424e-07
|
|
|
G6PD
|
[NCBI]
|
4.62194e-08
|
|
|
DHFR
|
[NCBI]
|
2.43743e-08
|
|